Where do Personalized Health Technologies stand today?
Keywords:Cancer precision medicine program, Car t cells, Data computing services, Immunotherapy, Metastatic lung cancer, Multiple sclerosis care, Prostate cancer
AbstractIn June 2018, experts met at ETH Zurich to discuss technological challenges in advanced cell systems, variant interpretation, novel therapeutics and the integration of clinical data. The translation of these technologies into innovative clinical approaches in oncology, immunology, infectious diseases, neurology and cardiology will be a challenge for the future. Detailed information at http://www.personalizedhealth.nexus.ethz.ch/
How to Cite
E. Heinzelmann, Chimia 2018, 72, 657, DOI: 10.2533/chimia.2018.657.
Columns, Conference Reports
Copyright (c) 2018 Swiss Chemical Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.